Simplified PI-RADS (S-PI-RADS) for biparametric MRI to detect and manage prostate cancer: What urologists need to know
- PMID: 35929870
- PMCID: PMC8260088
- DOI: 10.5152/tud.2021.21004
Simplified PI-RADS (S-PI-RADS) for biparametric MRI to detect and manage prostate cancer: What urologists need to know
Abstract
Biparametric magnetic resonance imaging (bpMRI) of the prostate has emerged as an alternative to multiparametric MRI (mpMRI) for the detection of clinically significant prostate cancer (csPCa). However, while the Prostate Imaging Reporting and Data System (PI-RADS) is widely known for mpMRI, a proper PI-RADS for bpMRI has not yet been adopted. In this review, we report the current status and the future directions of bpMRI, and propose a simplified PI-RADS (S-PI-RADS) that could help radiologists and urologists in the detection and management of PCa.
Conflict of interest statement
Figures




Similar articles
-
Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.J Magn Reson Imaging. 2021 Jan;53(1):283-291. doi: 10.1002/jmri.27283. Epub 2020 Jul 2. J Magn Reson Imaging. 2021. PMID: 32614123
-
Biparametric MRI of the prostate.Turk J Urol. 2017 Dec;43(4):401-409. doi: 10.5152/tud.2017.06978. Epub 2017 Dec 1. Turk J Urol. 2017. PMID: 29201499 Free PMC article. Review.
-
The diagnostic performance in clinically significant prostate cancer with PI-RADS version 2.1: simplified bpMRI versus standard mpMRI.Abdom Radiol (NY). 2023 Feb;48(2):704-712. doi: 10.1007/s00261-022-03750-8. Epub 2022 Dec 5. Abdom Radiol (NY). 2023. PMID: 36464756
-
MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI.Front Oncol. 2022 Jan 20;11:792456. doi: 10.3389/fonc.2021.792456. eCollection 2021. Front Oncol. 2022. PMID: 35127499 Free PMC article.
-
Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.Eur Urol Oncol. 2020 Apr;3(2):145-167. doi: 10.1016/j.euo.2020.02.005. Epub 2020 Mar 17. Eur Urol Oncol. 2020. PMID: 32192942 Free PMC article.
Cited by
-
Current Status of Biparametric MRI in Prostate Cancer Diagnosis: Literature Analysis.Life (Basel). 2022 May 28;12(6):804. doi: 10.3390/life12060804. Life (Basel). 2022. PMID: 35743835 Free PMC article. Review.
-
The role of gadolinium-based contrast agents in magnetic resonance imaging structured reporting and data systems (RADS).MAGMA. 2024 Feb;37(1):15-25. doi: 10.1007/s10334-023-01113-y. Epub 2023 Sep 13. MAGMA. 2024. PMID: 37702845 Free PMC article. Review.
References
-
- Drost FH, Osses D, Nieboer D, Bangma CH, Steyerberg EW, Roobol MJ, et al. Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane systematic review and meta-analysis. Eur Urol. 2020;77:78–94. doi: 10.1016/j.eururo.2019.06.023. - DOI - PubMed
-
- Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, et al. Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging and management of prostate cancer. J Urol. 2020;203:706–12. doi: 10.1097/JU.0000000000000617. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous